ZUH:CA:TSX-BMO Equal Weight US Health Care (CAD Hedged) (CAD)

ETF | Sector Equity |

Last Closing

CAD 61.02

Change

-0.74 (-1.20)%

Market Cap

CAD 0.21B

Volume

1.93K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-09 )

Largest Industry Peers for Sector Equity

Symbol Name Price(Change) Market Cap
TEC:CA TD Global Technology Leaders I..

+0.10 (+0.24%)

CAD 3.27B
ZWU:CA BMO Covered Call Utilities ETF

+0.02 (+0.18%)

CAD 1.83B
XIT:CA iShares S&P/TSX Capped Informa..

-1.00 (-1.51%)

CAD 0.72B
HTA:CA Harvest Tech Achievers Growth ..

+0.03 (+0.18%)

CAD 0.59B
ZUT:CA BMO Equal Weight Utilities Ind..

+0.09 (+0.37%)

CAD 0.57B
TXF:CA First Asset Tech Giants Covere..

-0.03 (-0.16%)

CAD 0.57B
XHC:CA iShares Global Healthcare (CAD..

-0.84 (-1.33%)

CAD 0.56B
XUT:CA iShares S&P/TSX Capped Utiliti..

-0.10 (-0.34%)

CAD 0.35B
CWW:CA iShares Global Water Common Cl..

+0.02 (+0.03%)

CAD 0.30B
HUTL:CA Harvest Equal Weight Global Ut..

-0.03 (-0.17%)

CAD 0.29B

ETFs Containing ZUH:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Sector Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -7.14% 37% F 20% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -7.14% 31% F 19% F
Trailing 12 Months  
Capital Gain -12.24% 20% F 14% F
Dividend Return 0.70% 26% F 11% F
Total Return -11.54% 14% F 14% F
Trailing 5 Years  
Capital Gain 1.13% 23% F 31% F
Dividend Return 2.75% 21% F 4% F
Total Return 3.88% 11% F 20% F
Average Annual (5 Year Horizon)  
Capital Gain 0.75% 26% F 35% F
Dividend Return 1.17% 14% F 26% F
Total Return 0.42% 29% F 20% F
Risk Return Profile  
Volatility (Standard Deviation) 13.62% 69% C- 59% D-
Risk Adjusted Return 8.59% 11% F 24% F
Market Capitalization 0.21B 62% D 46% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.